Guardant Health, Inc. (GH)
NASDAQ: GH · IEX Real-Time Price · USD
18.26
+0.26 (1.44%)
At close: May 1, 2024, 4:00 PM
18.94
+0.68 (3.72%)
After-hours: May 1, 2024, 7:07 PM EDT
Guardant Health Employees
Guardant Health had 1,779 employees on December 31, 2023. The number of employees decreased by 14 or -0.78% compared to the previous year.
Employees
1,779
Change (1Y)
-14
Growth (1Y)
-0.78%
Revenue / Employee
$317,003
Profits / Employee
-$269,505
Market Cap
2.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,779 | -14 | -0.78% |
Dec 31, 2022 | 1,793 | 420 | 30.59% |
Dec 31, 2021 | 1,373 | 509 | 58.91% |
Dec 31, 2020 | 864 | 242 | 38.91% |
Dec 31, 2019 | 622 | 168 | 37.00% |
Dec 31, 2018 | 454 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AMN Healthcare Services | 18,223 |
Teladoc Health | 5,600 |
Inari Medical | 1,300 |
Ginkgo Bioworks Holdings | 1,218 |
Privia Health Group | 1,102 |
Denali Therapeutics | 445 |
Arvinas | 445 |
Vericel | 314 |
GH News
- 9 days ago - FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 - Business Wire
- 13 days ago - Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire
- 4 weeks ago - Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting - Business Wire
- 7 weeks ago - Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine - Business Wire
- 2 months ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap - Business Wire
- 2 months ago - Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook - Business Wire
- 2 months ago - Guardant Health to Participate in Upcoming Investor Conferences - Business Wire